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Testosterone has been clinically used to improve hormone deﬁciency in the aging male; 
however, investigations how testosterone exerts its effects on lower urinary tract functions 
are not many.  In order to shed light on the efﬁcacy of testosterone on the functions, we 
replaced teststerone in elderly male Wistar rats aged 19 months.  A relevant dose (120 
mg) of testosterone was subcutaneously replaced through an implanted silastic tube into 
6 rats for 4 weeks (treated group).  Another 6 rats received no treatment for 4 weeks (con-
trol group).  After the end of the 4-week period, we measured plasma testesterone, weight 
of bladder, prostate and body, bladder muscle content, spontaneous micturition behavior 
and cystometric parameters, and compared the results between the 2 groups.  The daily 
micturition frequency (18.8 ± 1.5 times/day versus 15.5 ± 1.9 times/day), volume of resid-
ual urine at cystometry (0.66 ± 0.10 mL versus 0.24 ± 0.03 mL), bladder capacity (1.03 ± 
0.06 mL versus 0.65 ± 0.05 mL), bladder weight (258 ± 9 mg versus 198 ± 19 mg), prostate 
weight (2.08 ± 0.22 g versus 1.29 ± 0.22 g) and ratio of smooth muscle area/connective 
tissue area (3.59 ± 0.13 versus 2.59 ± 0.36) were signiﬁcantly higher in the treated group 
(P < 0.05).  In contrast, the average volume of spontaneous micturition was signiﬁcantly 
lower in the treated group (0.84 ± 0.07 mL versus 0.98 ± 0.09 mL).  Differences in body 
weight and volume of 24-h urine were not signiﬁcant between groups.  Daily micturi-
tion frequency and volume of residual urine at cystometry were increased in the treated 
group.  Testosterone replacement exerted unfavorable effects on the lower urinary func-
tions of elderly rats, including prostatic hypertrophy.
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Male hormone deﬁciency in the aging male is a 
popular topic among andrologists, endocrinolo-
gists and urologists (Lunenfeld, 2003).  Compared 
with normal ranges for young male adults, total 
serum testosterone levels are lower in 19% of men 
in their 60s, 28% of men in their 70s and 49% of 
men in their 80s (Harman, 2001).  Their bladder 
functions are frequently disrupted mostly by the 
secondary effects of central neural pathologies 
(senile dementia, cerebral vascular accident), ag-
ing and/or bladder outlet obstruction (Lluel et al., 
2003).  The bladder activity and various compo-
nents of bladder outlet are regulated by complex 
neural mechanisms.  During micturition reﬂexes, 
the nervous system coordinates the muscles of 
the detrusor, bladder neck and urethra to promote 
urine flow (Lluel et al., 2003), modulating the 
abilities of the lower urinary tract to store and re-
lease urine. 
 Micturition behavior changes with age (Chun 
et al., 1988), and aging males’ alpha adrenergic 
receptor density is reduced.  If chronic testoster-
one deficiency is prolonged, it might ultimately 
affect their bladder outlet resistance (Anderson et 
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al., 1988) and eventually cause functional disor-
ders of the lower urinary tract.  Male- and female-
hormone receptors are co-localized in the urothe-
lia, bladder smooth muscle cells, proximal urethra 
striated muscle cells and neurons in the autonom-
ic ganglia of the prostatic plexus, and together 
exert their effects directly on the lower urinary 
tract of aged males (Salmi et al., 2001; Keast et 
al., 1998).  Conditions induced by co-localization 
have recently drawn attention such as partial an-
drogen deﬁciency in aging males, andropause or 
male climacteric.  Patients are clinically treated 
with testosterone replacement via injection, orally 
or percutaneously (Jockenhovel, 2003) in order 
to alleviate subjective symptoms such as feeble-
ness with loss of concentration, decreased sexual 
desire, impotence and/or muscle amount degrada-
tion (Lunenfeld, 2003). 
 Generally, testosterone replacement is 
thought to have little influence on the lower uri-
nary tract, serum prostate-specific antigen and 
prostate volume (Holmang, 1993; Cooper, 1998; 
Leder et al., 2004).  However, in some animal ex-
periments, testosterone replacement has resulted 
in prostatic hypertrophy and lower urinary tract 
passage disorder (Constantinou, 1996), despite fa-
vorable results in the bladder functions of female 
hormone-replaced elderly female rats (Longhearst 
et al., 1992).  To study the effects of testosterone 
replacement on lower urinary tract functions in 
elderly male rats, we measured plasma testester-
one, bladder, prostate and body weight, bladder 
muscle content, spontaneous micturition behavior 
and cystometric parameters using testosterone-
replaced and non-treated rats.
Materials and Methods
Animals
Experiments were performed in accordance with 
the Guidelines of Tottori University Commit-
tee for Animal Experimentation at the Division 
of Laboratory Animal Science, Research Center 
for Biosience and Technology, Tottori University. 
The studied animals were 12 male Wistar rats 
aged 19 months (SLC, Shizuoka, Japan), reared 
in an air-conditioned room under a 12/12 h light/
dark cycle and allowed access to food and water 
ad libitum.  Of the 12, 6 received no treatment for 
4 weeks (control group).  The remaining 6 had 
subcutaneous implants for 4 weeks via a silastic 
tube (inside diameter, 2.5 mm; length, 30 mm) 
(Kaneda Medix, Osaka, Japan) containing 120 
mg of testosterone (Wako, Osaka, Japan) in sesa-
me oil (Kadoya, Tokyo, Japan) (the treated group) 
according the dose and method reported by Sato 
et al. (1998). 
Micturition behavior
After treatment, micturition behavior was moni-
tored for 24 h in a metabolic cage containing a 
urine collection funnel.  Urine ﬂowed through a 
duct into a 250-mL plastic beaker placed on an 
electronic balance (HF200, A.N.D., Tokyo), which 
was connected to a personal computer (Macintosh 
iBook G3, Apple Computer, Cupertino, CA) via 
a multi-port controller (Maclab/400, AD Instru-
ments, Castle Hill, Australia).  Volumes of spon-
taneous micturition were automatically sampled 
every 150 s for 24 h, and the data including mic-
turition frequency were stored on the compunter’s 
hard disk.  Monitoring per each group started at 
10:00.  The rats were allowed to take water but no 
food during the observation period. 
Cystometry
Cystometry was performed under subcutaneous 
urethane anesthesia (1.0 g/kg) with a 24-gauge 
catheter inserted into the apex of the bladder 
dome to record pressure.  On day 31 of the experi-
ment, the bladder was filled with physiological 
saline by using an infusion pump (5200, TOP, 
Tokyo) at a constant rate of 0.4 mL/min until 
micturition was detected.  A cystostomy catheter 
was connected to an external pressure transducer 
(P2310, Gould, Eastlake, OH) to measure the 
intravesical pressure, which was recorded on a 
Macintosh Powerbook G3 via a bridge ampliﬁer 
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(ML112, AD Instruments) and a multi-port con-
troller Maclab/400.  During micturition, ﬁlter pa-
per was carefully placed at the meatus to absorb 
excreted urine without spillage, and the excreted 
volume was calculated by the difference of the 
weight.  The following parameters were mea-
sured: bladder capacity (mL), volume of excreted 
urine (mL), volume of residual urine (mL) and 
maximal detrusor pressure (cmH2O).  Maximal 
detrusor pressure was defined as (instantaneous 
pressure of the detrusor muscle) minus (resting 
pressure of the detrusor muscle after contraction). 
The measurements were performed for 24 h per 
each rat.
Measurement of plasma testosterone and 
histological examination of the rat bladder 
Blood was drawn by a heart puncture and a vol-
ume of 2.5 mL was collected to assess the plasma 
testosterone level by radioimmunoassay kit (SRL, 
Tokyo).  After blood sampling, the bladder and 
prostate were surgically removed from the sur-
rounding tissues and weighed.  Bladders transect-
ed at the urethra level were sectioned into sagittal 
slices, fixed in 10% formalin and embedded in 
paraffin, from which 10 μm-thick vertical cross 
sections were made.  The sections were deparaf-
ﬁnized with xylene, rehydrated with a graded se-
ries of ethanol and stained with hematoxylin and 
eosin and the Elastica-van Gieson method which 
stains smooth muscles yellow and collagen in 
connective tissues red. 
Color-assisted quantitative image analysis
The stained smooth muscles were quantified by 
using color-assisted quantitative image analy-
sis.  Sections of stained tissues were observed 
at a magniﬁcation of 400 times by light micros-
copy (BX50, Olympus, Tokyo), displayed on a 
color monitor (PVM-20M4V, Sony, Tokyo) and 
printed with a digital color printer (CP700DSA, 
Mitsubishi, Tokyo).  Prints were digitized with a 
scanner (GT-8000, Epson, Tokyo) operated on a 
Macintosh Powerbook G3 (Apple Computer), and 
quantiﬁed by using National Institutes of Health 
Image 1.55 software (Research Service Branch, 
National Institutes of Health, Bethesda, MD). 
We then calculated the components of smooth 
muscles and connective tissues per full screen. 
At least 10 ﬁelds were examined from each tissue 
section. 
Statistical analysis
Experimental values are expressed as mean ± SD. 
Statistic probabilities were calculated with the 
non-parametric t-test between 2 groups, and P < 
0.05 was considered signiﬁcant. 
Results
Plasma testosterone levels
The treated group showed signiﬁcantly (P < 0.05) 
higher plasma testosterone levels than the control 
group (Table 1). 
Bladder, prostate and body weight
The bladder and prostate were significantly (P 
< 0.05) heavier in the treated group than in the 
control (Table 1).  The difference in body weight 
between groups was not signiﬁcant (Table 1).
Table 1. Plasma testosterone levels and weight 
of the rat bladder, prostate and body
 Control   Treated 
 group [6] group [6]
Testosterone (ng/mL) 0.83 ± 0.41 2.61 ± 0.69*
 
Bladder weight (mg) 198 ± 19 258 ± 9*
 
Prostate weight (g) 1.29 ± 0.22 2.08 ± 0.22*
 
Body weight (g) 575 ± 33 598 ± 26
 Values are mean ± SD. 
 [  ], number of animals.
* Signiﬁcant difference, P < 0.05.  
S. Morizane et al.
96
Fig. 1.  Light micrographic presentations of sections of the bladder body in elderly male rats (Elastica-van Gieson 
stain; original magniﬁ cation, × 400).  A: an untreated rat (control group).  B: a testosterone-replaced rat (treated 
group).
Table 2.  Ratio of smooth muscle area/connective tissue area
 Control group [6] Treated group [6]
Smooth muscle area/connective tissue area 2.59 ± 0.36 3.59 ± 0.13*
 Values are mean ± SD of 10 times or more measurements per each rat.
 [  ], number of animals.
* Signiﬁ cant difference, P < 0.05.
A
B
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Histological examination of the rat bladder
The smooth muscle area was significantly (P 
< 0.05) smaller in the control group than in the 
treated group (Fig. 1 and Table 2) 
Micturition behavior 
Micturition frequency was signiﬁcantly (P < 0.05) 
higher in the treated group than in the control 
group, but the difference in 24-h volume of urine 
was not signiﬁcant (Table 3).  The average volume 
of spontaneous micturition was signiﬁcantly (P < 
0.05) lower in the treated group than the control 
group (Table 3). 
Urodynamic study
Bladder capacity and volume of residual urine 
at cystometry were also significantly larger in 
the treated group.  The difference in volume of 
excreted urine at cystometry was not significant 
between groups (Table 4). 
 
Discussion
The influence of sex hormones upon the lower 
urinary tract is of interest.  Male and female 
hormones together regulate the development and 
functions of lower urinary tract muscles in male 
rats (Saija et al., 2001).  In humans, total plasma 
testosterone declines by approximately 1% per 
year on an average from the age of around 40 
years (Gray et al., 1991).  Due to the concomitant 
increase of sex hormone binding globulin, free 
testosterone levels decrease even more steeply 
from this age.  Nonbinding testosterone also de-
creases with aging (Feldman et al., 2002). 
 Testosterone exerts a powerful inﬂuence on 
male reproductive organs, including spermatogen-
esis and mounting behavior (Lunenfeld, 2003); 
however, its effects on lower urinary tract func-
tions have not been fully characterized.  In the 
present study on its effects on elderly male rats, 
the level of testosterone we replaced was accord-
Table 4. Comparison of urodynamic parameters
 Control group [6]  Treated group [6]
Bladder capacity (mL) 0.65 ± 0.05 1.03 ± 0.06*
Maximal detrusor pressure (cmH2O) 29.8 ± 1.3 34.5 ± 1.3*
Excreted urine† (mL) 0.42 ± 0.06 0.37 ± 0.07
Residual urine † (mL) 0.24 ± 0.03 0.66 ± 0.10*
 Values are mean ± SD. 
* Signiﬁcant difference, P < 0.05. 
† During cystometry to measure intravesical pressures.
Table 3. Comparison of micturition behavior
                     Measurement Control group [6]  Treated group [6]
24-h volume of urine (mL/day) 15.0 ± 0.8 15.8 ± 1.1
 
Daily micturition frequency (time/day)  15.5 ± 1.9 18.8 ± 1.5*
Volume of spontaneous micturition (mL) 0.98 ± 0.09 0.84 ± 0.07*
 Values are mean ± SD. 
 [  ], number of animals.
* Signiﬁcant difference, P < 0.05.
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ing to Sato et al. (1981).  They reported average 
plasma testosterone levels as 2.34 ± 0.21 ng/mL 
in 12-month-old rats and 0.78 ± 0.17 ng/mL in 
24-month-old rats.  The corresponding levels in 
our study were 2.61 ± 0.69 ng/mL in treated rats, 
almost the same as in their reproductive rats, and 
0.83 ± 0.41 ng/mL in control rats, almost the same 
as in their elderly rats. 
 The difference in mean body weight was not 
signiﬁcant between both groups.  The mean blad-
der weight was signiﬁcantly greater in the treated 
group than the control group.  Histologically, the 
amount of muscle tissues signiﬁcantly increased 
in the treated group, and the ratio of smooth mus-
cle area/connective tissue area was significantly 
higher in the treated group than in the control 
group.  The increase in muscle tissues caused an 
increase in bladder weight.  Prostate weight sig-
niﬁcantly increased in the treated rats as well. 
 In our observations of rat micturition behav-
ior, differences between the 2 groups were not 
signiﬁcant in 24-h volume of urine.  However, the 
treated group showed significantly higher daily 
micturition frequency and signiﬁcantly lower av-
erage spontaneous micturition.  Through cystom-
etry, the bladder capacity, the volume of residual 
urine and the maximal detrusor pressure were 
significantly higher in the treated group than in 
the control group. 
 The increase in the ratio of smooth muscle 
area/connective tissue area appeared to raise the 
detrusor pressure, and bladder capacity then in-
creased with bladder compliance, as we observed. 
Usually, average micturition volume increases 
and daily micturition frequency decrease; how-
ever, we observed different results in the present 
experiments, presumably because residual urine 
increased due to an increase in prostate weight. 
 As the structures of the prostate of the rat 
and the human are different, particularly in the 
way the ventral and dorsolateral prostate loops 
around the urethra without compression, the rat 
model could be considered to be non-obstructive. 
However, in the present study, testosterone re-
placement enlarged the prostate, which then com-
pressed the urethra.  Thus, lower urinary tract 
obstruction caused an increase in residual urine 
volume.  This disorder of the lower urinary tract 
passage caused the smooth muscle of the bladder 
to swell, and increased the ratio of smooth muscle 
area/connective tissue area, leading to an increase 
in detrusor pressure.  More studies will be ne-
cessry to ﬁnd out if these changes in the bladder 
are due to the direct effect of testosterone or the 
secondary effect of increased urethra resistance.
 In humans, testosterone replacement does 
not signiﬁcantly increase serum levels of prostate-
speciﬁc antigen or prostate volume (Ebert, 2004), 
and the lower urinary tract does not appear to be 
significantly influenced.  However, testosterone 
replacement caused prostatic hypertrophy and in-
ﬂuenced lower urinary tract function in the pres-
ent study with rats.  The prostate maintains the 
ability to respond to androgens throughout life 
and the proliferative response of prostatic cells 
to androgens depends on expression of the intra-
cellular androgen receptor.  Following prostate 
growth to its adult size, the rates of cell prolifera-
tion and cell death reach equilibrium, preventing 
further growth. 
 However, cellular hyperplasia occurs later 
in the lives of several species, including humans, 
dogs and some rat strains despite a decrease in 
testicular androgen production and a concomitant 
fall in the peripheral levels of androgen reaching 
the prostate (Banerjee et al., 2001).  The imbal-
ance in cell death and cell proliferation that leads 
to age-dependent prostatic hyperplasia might be 
related to increased prostatic sensitivity to andro-
gen.  Nuclear androgen receptor expression would 
be changed with cellular aging, and contribute 
to the evolution of cellular hyperplasia.  In fact, 
nuclear androgen receptor levels are higher in hy-
perplastic prostate tissues than in normal tissues 
(Barrack et al., 1983).  Age-related increases in 
the relative estrogen level, as well as other factors, 
might increase androgen receptor expression in 
the aging prostate.  Further growth or decrease in 
cell death results, although androgen is decreased 
in the peripheral circulation with normal dihy-
drotestosterone levels in the prostate. 
 In the present testosterone-replaced elderly 
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male rats, the amount of bladder smooth muscles, 
the ratio of smooth muscle area/connective tis-
sue area, bladder capacity and detrusor pressure 
were increased.  However, the prostates were 
swollen and lower urinary tract passage disorder 
was induced.  Average micturition volume was 
decreased, and daily micturition frequency in-
creased.  Testosterone replacement exerted unfa-
vorable effects on the lower urinary functions of 
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